Literature DB >> 8685051

Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells.

S D Cramer1, D M Peehl, M G Edgar, S T Wong, L J Deftos, D Feldman.   

Abstract

Parathyroid hormone-related protein (PTHrP) has previously been shown to be expressed in human prostatic tissue and in prostatic cancer cell lines. In the present study, PTHrP immunoreactivity was detected in the glandular epithelium of normal prostate and benign prostatic hyperplasia (BPH), as well as in prostatic adenocarcinoma (CaP). Epithelial cell cultures derived from normal, BPH, and CaP tissues were also stained by antibodies against PTHrP, and northern analysis revealed multiple transcripts of PTHrP in the cellular RNA. PTHrP (1-34) was measurable by radioimmunoassay (RIA) in media conditioned by the prostatic epithelial cell cultures, and PTHrP accumulated in conditioned media during a 72 hr time course. Addition of complete growth medium to starved cells resulted in increased PTHrP mRNA levels by 1 hr, with maximal stimulation at 8-24 hr. Several individual factors contained in the complete growth medium were tested for their ability to regulate PTHrP expression. Epidermal growth factor (EGF) was the major inducer of PTHrP expression, while cholera toxin, bovine pituitary extract, hydrocortisone, and insulin had minimal or no effect on PTHrP transcript levels. Since each of these factors is growth stimulatory, the unique ability of EGF to induce PTHrP is apparently unrelated to mitogenicity. 1,25-Dihydroxyvitamin D3[1,25(OH)2D3], an inhibitor of PTHrP expression in several other cell types, had no effect on steady-state levels of PTHrP mRNA expressed by epithelial cells in complete growth medium, although prostate cells have vitamin D receptors and are responsive to 1,25(OH)2D3 in other ways. Our results indicate that PTHrP expression is not confined to the neuroendocrine cells of the human prostate and that our culture system can be used as a model to investigate the role of PTHrP in the prostate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8685051     DOI: 10.1002/(SICI)1097-0045(199607)29:1<20::AID-PROS3>3.0.CO;2-M

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  9 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.

Authors:  John Foley; Nicole Nickerson; David J Riese; Peter C Hollenhorst; Gwendolen Lorch; Anne M Foley
Journal:  Odontology       Date:  2012-06-10       Impact factor: 2.634

Review 3.  PTHrP gene expression in cancer: do all paths lead to Ets?

Authors:  Virgile Richard; Thomas J Rosol; John Foley
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2005       Impact factor: 1.807

4.  Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.

Authors:  Giovanni Almadori; Antonella Coli; Eugenio De Corso; Dario Antonio Mele; Stefano Settimi; Giovanni Di Cintio; Francesca Brigato; Domenico Scannone; Libero Lauriola; Franco Oreste Ranelletti
Journal:  BMC Cancer       Date:  2022-06-27       Impact factor: 4.638

5.  Effect of parathyroid hormone related protein, and dihydrotestosterone on proliferation and ornithine decarboxylase mRNA in human prostate cancer cell lines.

Authors:  F Asadi; M Faraj; S Malakouti; S C Kukreja
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.

Authors:  Jennifer L Gilmore; Jeffrey A Scott; Zhor Bouizar; Alex Robling; Sarah E Pitfield; David J Riese; John Foley
Journal:  Breast Cancer Res Treat       Date:  2007-09-20       Impact factor: 4.872

7.  PTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3).

Authors:  Xiaoli Shen; Ramanjaneya V R Mula; Jing Li; Nancy L Weigel; Miriam Falzon
Journal:  Steroids       Date:  2007-08-15       Impact factor: 2.668

8.  Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases.

Authors:  A A G Bryden; J A Hoyland; A J Freemont; N W Clarke; N J R George
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

9.  Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression.

Authors:  Marta García; Carlos Javier Rodríguez-Hernández; Silvia Mateo-Lozano; Sara Pérez-Jaume; Eliana Gonçalves-Alves; Cinzia Lavarino; Jaume Mora; Carmen de Torres
Journal:  Mol Oncol       Date:  2019-07-19       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.